【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 13
2 Introduction 14
2.1 Cardiovascular Prosthetic Devices Overview 14
3 Products under Development 15
3.1 Cardiovascular Prosthetic Devices – Pipeline Products by Stage of Development 15
3.2 Cardiovascular Prosthetic Devices – Pipeline Products by Segment 16
3.3 Cardiovascular Prosthetic Devices – Pipeline Products by Territory 17
3.4 Cardiovascular Prosthetic Devices – Pipeline Products by Regulatory Path 18
3.5 Cardiovascular Prosthetic Devices – Pipeline Products by Estimated Approval Date 19
3.6 Cardiovascular Prosthetic Devices – Ongoing Clinical Trials 20
4 Cardiovascular Prosthetic Devices – Pipeline Products under Development by Companies 21
4.1 Cardiovascular Prosthetic Devices Companies – Pipeline Products by Stage of Development 21
4.2 Cardiovascular Prosthetic Devices – Pipeline Products by Stage of Development 24
5 Cardiovascular Prosthetic Devices Companies and Product Overview 27
5.1 4tech Cardio Ireland Limited Company Overview 27
5.1.1 4tech Cardio Ireland Limited Pipeline Products & Ongoing Clinical Trials Overview 27
5.2 Agamit Medical Ltd. Company Overview 29
5.2.1 Agamit Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 29
5.3 Ample Medical Inc. Company Overview 30
5.3.1 Ample Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
5.4 Amsel Medical Corporation Company Overview 31
5.4.1 Amsel Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 31
5.5 Aporo Biomedical, Inc. Company Overview 32
5.5.1 Aporo Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
5.6 Arbor Surgical Technologies, Inc. Company Overview 35
5.6.1 Arbor Surgical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
5.7 BioStable Science & Engineering, Inc. Company Overview 36
5.7.1 BioStable Science & Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
5.8 BioVentrix, Inc. Company Overview 40
5.8.1 BioVentrix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
5.9 CARAG AG Company Overview 44
5.9.1 CARAG AG Pipeline Products & Ongoing Clinical Trials Overview 44
5.10 Cardica, Inc. Company Overview 46
5.10.1 Cardica, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
5.11 Cardiosolutions, Inc. Company Overview 49
5.11.1 Cardiosolutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
5.12 Cardious, Inc. Company Overview 50
5.12.1 Cardious, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
5.13 Celyad SA Company Overview 51
5.13.1 Celyad SA Pipeline Products & Ongoing Clinical Trials Overview 51
5.14 Children’s Hospital Boston Company Overview 53
5.14.1 Children’s Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 53
5.15 Cierra, Inc. (Inactive) Company Overview 57
5.15.1 Cierra, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 57
5.16 CoAptus Medical Corporation Company Overview 58
5.16.1 CoAptus Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 58
5.17 CollPlant Ltd. Company Overview 60
5.17.1 CollPlant Ltd. Pipeline Products & Ongoing Clinical Trials Overview 60
5.18 coramaze technologies GmbH Company Overview 61
5.18.1 coramaze technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 61
5.19 Cordis Corporation Company Overview 62
5.19.1 Cordis Corporation Pipeline Products & Ongoing Clinical Trials Overview 62
5.20 Coroneo Inc. Company Overview 63
5.20.1 Coroneo Inc. Pipeline Products & Ongoing Clinical Trials Overview 63
5.21 CUBE SRL Company Overview 64
5.21.1 CUBE SRL Pipeline Products & Ongoing Clinical Trials Overview 64
5.22 Edwards Lifesciences Corporation Company Overview 65
5.22.1 Edwards Lifesciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 65
5.23 Emory University Company Overview 72
5.23.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 72
5.24 Guided Delivery Systems, Inc. Company Overview 75
5.24.1 Guided Delivery Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 75
5.25 Instituto de investigacion sanitaria Marques de Valdecilla Company Overview 78
5.25.1 Instituto de investigacion sanitaria Marques de Valdecilla Pipeline Products & Ongoing Clinical Trials Overview 78
5.26 IPI Singapore Company Overview 79
5.26.1 IPI Singapore Pipeline Products & Ongoing Clinical Trials Overview 79
5.27 Kardium Inc. Company Overview 80
5.27.1 Kardium Inc. Pipeline Products & Ongoing Clinical Trials Overview 80
5.28 Lartim Medical Ltd Company Overview 81
5.28.1 Lartim Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 81
5.29 Lifetech Scientific (Shenzhen) Co., Ltd. Company Overview 82
5.29.1 Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 82
5.30 Mardil Medical, Inc. Company Overview 83
5.30.1 Mardil Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 83
5.31 Mayo Clinic. Company Overview 84
5.31.1 Mayo Clinic. Pipeline Products & Ongoing Clinical Trials Overview 84
5.32 Medtentia AB Company Overview 85
5.32.1 Medtentia AB Pipeline Products & Ongoing Clinical Trials Overview 85
5.33 MiCardia Corporation Company Overview 89
5.33.1 MiCardia Corporation Pipeline Products & Ongoing Clinical Trials Overview 89
5.34 Michigan Critical Care Consultants, Inc. Company Overview 92
5.34.1 Michigan Critical Care Consultants, Inc. Pipeline Products & Ongoing Clinical Trials Overview 92
5.35 Middle Peak Medical, Inc Company Overview 94
5.35.1 Middle Peak Medical, Inc Pipeline Products & Ongoing Clinical Trials Overview 94
5.36 Millipede, LLC Company Overview 95
5.36.1 Millipede, LLC Pipeline Products & Ongoing Clinical Trials Overview 95
5.37 Mitral Heal Company Overview 96
5.37.1 Mitral Heal Pipeline Products & Ongoing Clinical Trials Overview 96
5.38 Mitralign, Inc. Company Overview 97
5.38.1 Mitralign, Inc. Pipeline Products & Ongoing Clinical Trials Overview 97
5.39 Mitralix Ltd. Company Overview 105
5.39.1 Mitralix Ltd. Pipeline Products & Ongoing Clinical Trials Overview 105
5.40 Mitre Medical Corp. Company Overview 106
5.40.1 Mitre Medical Corp. Pipeline Products & Ongoing Clinical Trials Overview 106
5.41 MValve Technologies Ltd. Company Overview 108
5.41.1 MValve Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 108
5.42 Neochord, Inc. Company Overview 109
5.42.1 Neochord, Inc. Pipeline Products & Ongoing Clinical Trials Overview 109
5.43 Occlutech International AB Company Overview 112
5.43.1 Occlutech International AB Pipeline Products & Ongoing Clinical Trials Overview 112
5.44 Phoenix Cardiac Devices, Inc. Company Overview 119
5.44.1 Phoenix Cardiac Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 119
5.45 QuantumCor Inc. (Inactive) Company Overview 120
5.45.1 QuantumCor Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 120
5.46 ReCor Medical, Inc. Company Overview 121
5.46.1 ReCor Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 121
5.47 SCR, Inc. Company Overview 124
5.47.1 SCR, Inc. Pipeline Products & Ongoing Clinical Trials Overview 124
5.48 SeptRx, Inc. Company Overview 125
5.48.1 SeptRx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 125
5.49 Sorin S.p.A. (Inactive) Company Overview 128
5.49.1 Sorin S.p.A. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 128
5.50 St. Jude Medical, Inc. Company Overview 130
5.50.1 St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 130
5.51 Sutura, Inc. (Inactive) Company Overview 137
5.51.1 Sutura, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 137
5.52 Swissimplant AG (Inactive) Company Overview 139
5.52.1 Swissimplant AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 139
5.53 The Tel Aviv Sourasky Medical Center Company Overview 141
5.53.1 The Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview 141
5.54 TransCardiac Therapeutics, LLC Company Overview 142
5.54.1 TransCardiac Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 142
5.55 Trinity College Dublin Company Overview 143
5.55.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 143
5.56 University of Minnesota Company Overview 144
5.56.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 144
5.57 Valcare Medical Company Overview 145
5.57.1 Valcare Medical Pipeline Products & Ongoing Clinical Trials Overview 145
5.58 Valtech Cardio Ltd. Company Overview 146
5.58.1 Valtech Cardio Ltd. Pipeline Products & Ongoing Clinical Trials Overview 146
5.59 Viacor, Inc. Company Overview 153
5.59.1 Viacor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 153
5.60 Vir(Sn), Inc. Company Overview 156
5.60.1 Vir(Sn), Inc. Pipeline Products & Ongoing Clinical Trials Overview 156
5.61 W. L. Gore & Associates, Inc. Company Overview 157
5.61.1 W. L. Gore & Associates, Inc. Pipeline Products & Ongoing Clinical Trials Overview 157
6 Cardiovascular Prosthetic Devices- Recent Developments 162
7 Appendix 184
7.1 Methodology 184
7.2 About GlobalData 186
7.3 Contact Us 187
7.4 Disclaimer 187
【レポート販売概要】
■ タイトル：世界の人工心血管置換装置開発動向：医療機器パイプライン分析2015■ 英文：Cardiovascular Prosthetic Devices - Medical Devices Pipeline Assessment, 2015
■ 発行日：2016年1月1日
■ 調査会社：GlobalData
■ 商品コード：GDME0139EPD
■ 調査対象地域：グローバル
- 非破壊検査装置の世界市場：超音波探傷試験、放射線透過試験、目視試験About NDT Equipment NDT equipment is used to evaluate and examine the properties of an object, material, or system without damaging it. The equipment includes three major components: ultrasonic, radiography, and visual test equipment. The major end-users of NDT equipment are industries in the Power Generation, Oil and Gas, Aerospace, and Automotive sectors. TechNavio's analysts forecast the Global …
- 境界侵入防止システム（IPS）の世界市場：アクセス制御、警報・通報システム、監視装置About perimeter intrusion prevention systems Perimeter intrusion prevention systems include mechanical and electronic systems that protect the external perimeter of a facility, preventing unauthorized personnel from entering it. An increase in the number of violent attacks is the main reason for damage to property and loss of human lives. Intrusion into any critical infrastructure may lead to disr …
- マルチフィルムの世界市場：透明マルチ、ブラックマルチ、着色マルチ、分解性マルチThe global mulch films market has grown exponentially in the last few years. The market size is projected to reach USD 4.07 Billion by 2020, at a CAGR of around 6.5% from 2015 to 2020. Emerging countries such as India and China are the primary targets of the industry. Factors such as increasing demand for food and growing population are the major driving factors for this market. The mulch film mar …
- 製薬用濾過の世界市場予測（～2022）：濾過製品（メンブレンフィルター、シングルユース）、濾過技術、用途、規模The global pharmaceutical filtration market is projected to reach USD 22.71 Billion by 2021 from USD 13.73 Billion in 2016, at a CAGR of 10.6% during the forecast period. Growth in the market for pharmaceutical filtration is primarily driven by factors such as growth in the production of biopharmaceuticals, technological advancements in filtration equipment, and rapid growth in generics production …
- 暴動取り締まり装置の世界市場2016-2020About Riot Control System Law enforcement agencies use riot control systems to maintain public order and safety and to enforce laws. They are used to disperse, control, and arrest people involved in riots and protests. Riot control systems include lethal and non-lethal weapons (NWLs), body-worn cameras, armored vehicles, and communications systems. The agencies involved in riot control operations …
- 移行上皮癌(尿路上皮癌)(Transitional Cell Cancer (Urothelial Cell Cancer))：治療薬開発パイプライン動向（2015年上半期版）Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015’, provides an overview of the Transitional Cell Cancer (Urothelial Cell Cancer)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Transitional Cell Cancer ( …
- バニリン酸の世界市場Vanillic Acid (CAS 121-34-6) Market Research Report 2013 presents comprehensive data on vanillic acid markets globally and regionally (Europe, Asia, North America etc.) The Vanillic Acid (CAS 121-34-6) Market Research Report 2013 includes vanillic acid description, covers its application areas and related patterns. It overviews vanillic acid market, names vanillic acid producers and indicates its …
- 自動車用OEM高級オーディオの世界市場2019-2023About this market The global luxury vehicle market is witnessing growth in popularity and their demand year-on-year, which has accelerated the sales volume of premium or luxury vehicles. Luxury vehicles find a high penetration rate of advanced comfort and convenience functionalities, which also increases their value proposition. The growth in volume sales of vehicles from such luxury automakers is …
- 世界のWireless Gigabit (WiGig)市場動向(2014 – 2019)Wireless Gigabit (WiGig) is a short range in-room wireless technology, operating in the unlicensed 60 GHz range. WiGig transfers data content at the speed of 7Gbps, 10 times faster than the existing Wi-Fi technology. It can transfer audio, high definition video, multimedia applications and any kind of backup data at high speed, over a distance of 10 to 12 meters without the need of wires. The tech …
- 世界の侵入検知＆防止システム市場：コンポーネント別（ソリューション、サービス）、種類別、展開種類別（クラウド、オンプレミス）、エンドユーズ別、組織規模別（中小企業および大企業）、業種別、地域別An increase in the number of security breaches and cyberattacks faced by organizations is driving the growth of the global intrusion detection and prevention systems market The global Intrusion Detection and Prevention Systems (IDPS) market size is projected to grow from USD 4.7 billion in 2019 to USD 7.1 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 8.3% from 2019 to 2024. An increa …
- クイックサービスレストラン（ファーストフードレストラン）の世界市場About quick service restaurant A quick service restaurant (QSR) or a fast food restaurant is a specific type of restaurant that serves swiftly prepared fast food and includes both sweet and savory dishes in the menu. The concept of quick service restaurant originated in the US in the 1920s, and at present they are considered to be one of the most popular hangouts for teenagers, families, and young …
- ファシリティマネジメント（FM）ソリューションの世界市場予測（～2021）The facility management market is estimated to grow from USD 28.90 Billion in 2016 to USD 56.67 Billion by 2021, at a high Compound Annual Growth Rate (CAGR) of 14.42% during the forecast period. Facility management solutions are gaining significant importance among organizations as they facilitate agility and efficiency in business functioning. The facility management concept comprises software a …
- ネットワークコンサルティングの世界市場2017-2021About Network ConsultingNetwork consulting services refer to the advisory services provided to help companies analyze and improve the operational performance and technology strategies. The services in this segment are focused on areas such as e-commerce, telecommunications, hardware system design and implementation, software design, acquisition and implementation, website design, and operation. Te …
- ヨーロッパのガス処理産業Gas Processing Industry Outlook in Europe to 2020 - Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Processing Plants Summary "Gas Processing Industry Outlook in Europe to 2020 - Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Processing Plants" is a comprehensive report on gas processing industry in Europe. The report provi …
- 世界の自動車用マイクロコントローラ市場動向（2012-2016）TechNavio's analysts forecast the Global Automotive Microcontrollers market to grow at a CAGR of 0.69 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for electronic content in vehicles. The Global Automotive Microcontrollers market has also been witnessing the advent of next-generation microcontrollers. However, the increasing d …
